Marrone Bio Innovations Inc (MBII) Forecast, Price Target & Analyst Ratings
NASDAQ:MBII • US57165B1061
0.7981
-0.2 (-20.19%)
At close: Jul 12, 2022
0.81
+0.01 (+1.49%)
After Hours: 7/12/2022, 8:00:01 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Marrone Bio Innovations Inc (MBII).
Forecast Snapshot
Consensus Price Target
$1.40
+ 75.73% Upside
Next Earnings Forecast
Release DateAug 15, 2022
PeriodQ2 / 2022
EPS Estimate-$0.04
Revenue Estimate16.32M
ChartMill Buy Consensus
78.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$1.40
Upside
+ 75.73%
From current price of $0.80 to mean target of $1.40, Based on 10 analyst forecasts
Low
$0.91
Median
$1.33
High
$2.10
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
10 analysts have analysed MBII and the average price target is 1.4 null. This implies a price increase of 75.73% is expected in the next year compared to the current price of 0.7981.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
78.00%
MBII was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about MBII.
In the previous month the buy percentage consensus was at a similar level.
MBII was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-09-22 | Roth Capital | Initiate | Buy |
| 2021-08-19 | Aegis Capital | Maintains | Buy |
| 2021-02-11 | Aegis Capital | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateAug 15, 2022
PeriodQ2 / 2022
EPS Estimate-$0.04
Revenue Estimate16.32M
Revenue Q2Q29.52%
EPS Q2Q-104.00%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
MBII is expected to report earnings on 8/15/2022. The consensus EPS estimate for the next earnings is -0.04 null and the consensus revenue estimate is 16.32M null.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.37M 38.41% | 38.37M 30.64% | 44.31M 15.48% | 57.579M 29.95% | 72.42M 25.78% | 91.8M 26.76% | 113.641M 23.79% | 143.492M 26.27% | |
| EBITDA YoY % growth | -25.64M -45.52% | -13.64M 46.80% | -11.87M 12.98% | -4.026M 66.08% | 4.182M 203.86% | 3.049M -27.10% | 2.267M -25.64% | N/A | |
| EBIT YoY % growth | -27.99M -43.46% | -17.2M 38.55% | -15.4M 10.47% | -12.954M 15.88% | -3.57M 72.44% | -4.971M -39.25% | -7.061M -42.03% | N/A | |
| Operating Margin | -95.30% | -44.83% | -34.76% | -22.50% | -4.93% | -5.42% | -6.21% | N/A | |
| EPS YoY % growth | -0.27 -55.71% | -0.15 44.44% | -0.10 33.33% | -0.11 -7.10% | -0.02 80.95% | -0.02 | -0.03 -37.72% | -0.04 -40.48% |
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q2 / 22 | Q3 / 22 | Q4 / 22 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.04 -104.00% | -0.04 -36.00% | -0.04 -36.00% |
| Revenue Q2Q % growth | 16.32M 29.52% | 15.606M 58.28% | 13.77M 27.26% |
| EBITDA Q2Q % growth | -102K 83.28% | 306K 117.29% | -102K 95.10% |
| EBIT Q2Q % growth | -1.836M 22.20% | -2.04M 53.74% | -1.938M 65.45% |
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.55%
EPS Next 5 Year
9.93%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
27.21%
Revenue Next 5 Year
26.33%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
Marrone Bio Innovations Inc / MBII Forecast FAQ
Can you provide the average price target for Marrone Bio Innovations Inc stock?
10 analysts have analysed MBII and the average price target is 1.4 null. This implies a price increase of 75.73% is expected in the next year compared to the current price of 0.7981.
When does Marrone Bio Innovations Inc (MBII) report earnings?
Marrone Bio Innovations Inc (MBII) will report earnings on 2022-08-15, after the market close.
What are the consensus estimates for Marrone Bio Innovations Inc (MBII) next earnings?
The consensus EPS estimate for the next earnings of Marrone Bio Innovations Inc (MBII) is -0.04 null and the consensus revenue estimate is 16.32M null.
What is the expected long term growth rate for Marrone Bio Innovations Inc (MBII)?
The expected long term growth rate for Marrone Bio Innovations Inc (MBII) is 27.21%.